The following items discuss immunoglobulin mutational status.
Rai Interview Part 7: Research Partnership with Chiorazzi
Dr. Kanti Rai discusses how he met Dr. Nicholas Chiorazzi and they developed their research partnership studying IGHV mutational status and clinical staging. He notes that their model of partnership, which has involved collaboration between laboratory research and clinical practice, has been fruitful for both research and practice, and discusses how this same model developed in the Chronic Lymphocyctic Leukemia Research Consortium (CRC).
Highlights from an interview with Dr. Terence Hamblin discussing the development of his research, including idiotypes, cold agglutinin disease, and immunoglobulin mutational status.
CLL Digital Archive 